|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
11
|
|
pubmed:dateCreated |
2010-11-11
|
|
pubmed:abstractText |
To evaluate the effect of agalsidase beta on longitudinal health-related quality of life in patients with Fabry disease.
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Nov
|
|
pubmed:issn |
1530-0366
|
|
pubmed:author |
pubmed-author:BanikazemiMaryamM,
pubmed-author:Beitner-JohnsonDanaD,
pubmed-author:BurlinaAlessandro PAP,
pubmed-author:CazzorlaChiaraC,
pubmed-author:Feldt-RasmussenUllaU,
pubmed-author:HopkinRobert JRJ,
pubmed-author:MartinsAna MariaAM,
pubmed-author:O'BrienFannyF,
pubmed-author:SchönfeldDorotheeD,
pubmed-author:SimsKatherineK,
pubmed-author:WattTorquilT
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
12
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
703-12
|
|
pubmed:meshHeading |
pubmed-meshheading:20885332-Adult,
pubmed-meshheading:20885332-Aged,
pubmed-meshheading:20885332-Fabry Disease,
pubmed-meshheading:20885332-Female,
pubmed-meshheading:20885332-Health Surveys,
pubmed-meshheading:20885332-Humans,
pubmed-meshheading:20885332-Isoenzymes,
pubmed-meshheading:20885332-Male,
pubmed-meshheading:20885332-Middle Aged,
pubmed-meshheading:20885332-Quality of Life,
pubmed-meshheading:20885332-Registries,
pubmed-meshheading:20885332-Treatment Outcome,
pubmed-meshheading:20885332-Young Adult,
pubmed-meshheading:20885332-alpha-Galactosidase
|
|
pubmed:year |
2010
|
|
pubmed:articleTitle |
Agalsidase beta treatment is associated with improved quality of life in patients with Fabry disease: findings from the Fabry Registry.
|
|
pubmed:affiliation |
Department of Endocrinology, National University Hospital, Copenhagen, Denmark.
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
